Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409328 · ClinicalTrials.gov registry record · NA
Understanding and Reducing HIV Risk Behavior and Substance Use Among Self-identified Bisexual Adolescent Men
A NA study, sponsored by Rosalind Franklin University of Medicine and Science.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT03409328: Completed NA study, sponsored by Rosalind Franklin University of Medicine and Science.
NCT03409328 is a NA study that has completed, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03409328, a NA study, has completed, sponsored by Rosalind Franklin University of Medicine and Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Young gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. Despite this burden, most HIV prevention interventions target adult MSM (most of whom identify as gay) and heterosexual youth, creating an urgent need for interventions for gay and bisexual adolescents. Further, self-identified bisexual men, especially adolescents, have been neglected in research. Therefore, little is known about factors that drive engagement in risk behavior among self-identified bisexual adolescent men. The goals of this study are to: (1) examine factors that drive engagement in HIV risk behavior and substance use among self-identified bisexual adolescent men; and (2) develop and pilot test a tailored HIV and substance use prevention intervention for this population.
Primary Outcome
Retention from enrollment through the 1-month follow-up assessment.
Interventions
- BEHAVIORAL HIV and substance use prevention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-11 |
| Est. Completion | 2022-01-31 |
| Phase | NA |
What the finished NCT03409328 record still lists
NCT03409328 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which HIV and substance use prevention is the first listed.
NCT03409328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03409328 about?
NCT03409328 is a clinical study titled "Understanding and Reducing HIV Risk Behavior and Substance Use Among Self-identified Bisexual Adolescent Men". Young gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. Despite this burden, most HIV prevention interventions target adult MSM (most of whom identify as gay) and heterosexual youth, creating an urgent need for interventions for gay and bisexual adolesc...
What is the current status of trial NCT03409328?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-06-11. Estimated completion is 2022-01-31.
What interventions are being tested in trial NCT03409328?
The interventions under investigation include: HIV and substance use prevention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03409328?
This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03409328's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI